Generate a tailored SOP for Dr. Andrew West. Improve your application with a focused, well-structured draft.
Andrew Bradley West is a tenured Professor with a primary appointment in the Department of Pharmacology and Cancer Biology at Duke University and secondary appointments in Neurology, Neurobiology, and Cell Biology. His research focuses on the critical mechanisms and biomarkers of neurodegeneration and the therapeutic targets for disease modification strategies, particularly involving LRRK2 and alpha-synuclein. He is a founding member of the Parkinson Disease Biomarker Program steering committee and has served on the Executive Scientific Advisory Board of the Michael J. Fox Foundation. His academic training includes research on Ab toxicity and genetics related to Parkinson's disease, and he has worked with prominent researchers in the field. West has authored more than 100 publications and has been recognized for his innovative research, including his laboratory's role in sharing resources with the broader scientific community. He has held various funding awards and played a significant role in neurodegeneration research at Duke University since 2018.
Duke University • Durham, NC
Professor with a focus on neurobiology and pharmacology, contributing to research and education.
Department of Biomedical Engineering (MS program)